ScoreWhy is Windlas Biotech Ltd ?
1
Poor long term growth as Operating profit has grown by an annual rate 16.10% of over the last 5 years
2
Underperformed the market in the last 1 year
- Even though the market (BSE500) has generated returns of 2.12% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -29.09% returns
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Windlas Biotech for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Windlas Biotech
-29.2%
-0.63
46.44%
Sensex
4.83%
0.41
11.83%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
16.53%
EBIT Growth (5y)
16.10%
EBIT to Interest (avg)
33.76
Debt to EBITDA (avg)
0.19
Net Debt to Equity (avg)
-0.43
Sales to Capital Employed (avg)
1.37
Tax Ratio
23.50%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
12.54%
ROCE (avg)
21.98%
ROE (avg)
11.97%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
24
Industry P/E
34
Price to Book Value
3.04
EV to EBIT
18.61
EV to EBITDA
13.25
EV to Capital Employed
4.58
EV to Sales
1.68
PEG Ratio
2.67
Dividend Yield
0.75%
ROCE (Latest)
24.60%
ROE (Latest)
12.60%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
Bullish
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend11What is working for the Company
NET SALES(Q)
Highest at Rs 222.40 cr
PBDIT(Q)
Highest at Rs 28.56 cr.
OPERATING PROFIT TO NET SALES(Q)
Highest at 12.84%
PBT LESS OI(Q)
Highest at Rs 19.94 cr.
PAT(Q)
Highest at Rs 17.80 cr.
EPS(Q)
Highest at Rs 8.44
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Windlas Biotech
Net Sales - Quarterly
Highest at Rs 222.40 cr and Grown
each quarter in the last five quartersMOJO Watch
Near term sales trend is very positive
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs 28.56 cr. and Grown
each quarter in the last five quartersMOJO Watch
Near term Operating Profit trend is quite positive
Operating Profit (Rs Cr)
Operating Profit Margin - Quarterly
Highest at 12.84%
in the last five quartersMOJO Watch
Company's efficiency has improved
Operating Profit to Sales
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 19.94 cr.
in the last five quartersMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 19.94 cr has Grown at 21.6% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 16.40 CrMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
Highest at Rs 17.80 cr.
in the last five quartersMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Earnings per Share (EPS) - Quarterly
Highest at Rs 8.44
in the last five quartersMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (Rs)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
